Cover Image
Market Research Report

Non-Invasive Prenatal Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Published by Transparency Market Research Product code 320980
Published Content info 186 Pages
Delivery time: 1-2 business days
Price
Back to Top
Non-Invasive Prenatal Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
Published: May 23, 2019 Content info: 186 Pages
Description

Title:
Non-Invasive Prenatal Testing Market (Test Type - Materni21, Harmony, Panorama, Verifi, NIFTY; Application - Trisomy, Microdeletions Symptoms, Others (Including Sex Chromosomes Disorders); Technology - NGS, WGS; End use - Hospitals, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Global Non-Invasive Prenatal Testing Market: Overview

Non-invasive prenatal testing (NIPT) is a novel genetic screening method based on the analysis of cell-free fetal DNA in the maternal plasma.

The market for non-invasive prenatal testing is expanding significantly, worldwide, primarily due to increasing incidences of chromosomal aneuploidies among fetus, rising demand for early and non-invasive screening procedures, and rise in advanced maternal age (earlier 23 to 26 years has increased to 30 years).

The global non-invasive prenatal testing market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on test type, application, technology, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global non-invasive prenatal testing market.

Global Non-Invasive Prenatal Testing Market: Key Segments

Based on test type, the global non-invasive prenatal testing market has been classified into Materni21, Harmony, Panorama, Verifi, NIFTY, and others.

In terms of application, the global non-invasive prenatal testing market has been divided into Trisomy, Microdeletions symptoms, and others (sex chromosomes disorders).

Based on technology, the global non-invasive prenatal testing market has been classified into NGS (next generation sequencing), WGS (whole genome sequencing), and others.

In terms of end user, the global non-invasive prenatal testing market has been split into hospitals, diagnostic laboratories, and others.

The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Non-Invasive Prenatal Testing Market: Regional Outlook

In terms of region, the global non-invasive prenatal testing market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Malaysia, Thailand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and GCC Countries).

The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, Test Type, business strategies, and recent developments.

Major companies profiled in the global market are:

  • Berry Genetics
  • BGI
  • Laboratory Corporation of America Holdings
  • Agilent Technologies, Inc.
  • Illumina, Inc
  • F. Hoffmann-La Roche Ltd
  • NATERA, INC.
  • PerkinElmer Inc
  • Eurofins LifeCodexx AG
  • IGENOMIX.

The global non-invasive prenatal testing market has been segmented as follows:

Global Non-Invasive Prenatal Testing Market, by Test Type

  • Materni21
  • Harmony
  • Panorama
  • Verifi
  • NIFTY
  • Others

Global Non-Invasive Prenatal Testing Market, by Application

  • Trisomy
  • Microdeletions Symptoms
  • Others (Including Sex Chromosomes Disorders)

Global Non-Invasive Prenatal Testing Market, by Technology

  • NGS
  • WGS
  • Others

Global Non-Invasive Prenatal Testing Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Global Non-Invasive Prenatal Testing Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U,K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights
  • 1.3. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Test Type Definition
  • 4.2. Key Industry Evolution/Developments
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Increasing cases of Down's Syndrome
      • 4.3.1.2. Rising maternal age
      • 4.3.1.3. Increasing demand for early and non-invasive fetal testing procedures
    • 4.3.2. Restraints
      • 4.3.2.1. Regulatory guidelines
      • 4.3.2.2. Limitations of NIPT
      • 4.3.2.3. Other alternatives
    • 4.3.3. Opportunities
      • 4.3.3.1. Emerging markets in Asia Pacific
  • 4.4. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, 2017-2027
  • 4.5. Porter's Five Forces Analysis

5. Market Outlook

  • 5.1. Cost Comparison Analysis
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Technological Advancements

6. Global Non-Invasive Prenatal Testing Market, by Test Type

  • 6.1. Key Findings
  • 6.2. Global Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2019 and 2027
    • 6.2.1. Materni21
    • 6.2.2. Harmony
    • 6.2.3. Panorama
    • 6.2.4. Verifi
    • 6.2.5. NIFTY
    • 6.2.6. Others
  • 6.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 6.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Test Type
  • 6.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027

7. Global Non-Invasive Prenatal Testing Market, by Application

  • 7.1. Key Findings
  • 7.2. Global Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 7.2.1. Trisomy
    • 7.2.2. Microdeletions Symptoms
    • 7.2.3. Others (Including Sex Chromosomes Disorders)
  • 7.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 7.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Application
  • 7.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027

8. Global Non-Invasive Prenatal Testing Market, by Technology

  • 8.1. Key Findings
  • 8.2. Global Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 8.2.1. NGS
    • 8.2.2. WGS
    • 8.2.3. Others
  • 8.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 8.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Technology
  • 8.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027

9. Global Non-Invasive Prenatal Testing Market, by End-user

  • 9.1. Key Findings
  • 9.2. Global Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic Laboratories
    • 9.2.3. Others
  • 9.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 9.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by End-user
  • 9.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027

10. Global Non-Invasive Prenatal Testing Market, by Region

  • 10.1. Key Findings
  • 10.2. Global Non-Invasive Prenatal Testing Market Value Share, by Region, 2018 and 2027
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Region, 2019-2027
  • 10.4. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Region, 2017-2027

11. North America Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019-2027

  • 11.1. Key Findings
  • 11.2. North America Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
    • 11.2.1. Materni21
    • 11.2.2. Harmony
    • 11.2.3. Panorama
    • 11.2.4. Verifi
    • 11.2.5. NIFTY
    • 11.2.6. Others
  • 11.3. North America Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 11.4. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • 11.5. North America Non-Invasive Prenatal Testing Market, by Application
  • 11.6. Key Findings
  • 11.7. North America Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 11.7.1. Trisomy
    • 11.7.2. Microdeletions Symptoms
    • 11.7.3. Others (Including Sex Chromosomes Disorders)
  • 11.8. North America Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 11.9. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • 11.10. North America Non-Invasive Prenatal Testing Market, by Technology
  • 11.11. Key Findings
  • 11.12. North America Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 11.12.1. NGS
    • 11.12.2. WGS
    • 11.12.3. Others
  • 11.13. North America Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 11.14. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • 11.15. North America Non-Invasive Prenatal Testing Market, by End-user
  • 11.16. Key Findings
  • 11.17. North America Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 11.17.1. Hospitals
    • 11.17.2. Diagnostic Laboratories
    • 11.17.3. Others
  • 11.18. North America Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 11.19. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • 11.20. North America Non-Invasive Prenatal Testing Market, by Country
  • 11.21. Key Findings
  • 11.22. North America Non-Invasive Prenatal Testing Market Value Share, by Country, 2018 and 2027
    • 11.22.1. U.S.
    • 11.22.2. Canada
  • 11.23. North America Non-Invasive Prenatal Testing Market Attractiveness, by Country, 2019-2027
  • 11.24. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country, 2017-2027

12. Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019-2027

  • 12.1. Key Findings
  • 12.2. Europe Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
    • 12.2.1. Materni21
    • 12.2.2. Harmony
    • 12.2.3. Panorama
    • 12.2.4. Verifi
    • 12.2.5. NIFTY
    • 12.2.6. Others
  • 12.3. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 12.4. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • 12.5. Europe Non-Invasive Prenatal Testing Market, by Application
  • 12.6. Key Findings
  • 12.7. Europe Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 12.7.1. Trisomy
    • 12.7.2. Microdeletions Symptoms
    • 12.7.3. Others (Including Sex Chromosomes Disorders)
  • 12.8. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 12.9. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • 12.10. Europe Non-Invasive Prenatal Testing Market, by Technology
  • 12.11. Key Findings
  • 12.12. Europe Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 12.12.1. NGS
    • 12.12.2. WGS
    • 12.12.3. Others
  • 12.13. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 12.14. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • 12.15. Europe Non-Invasive Prenatal Testing Market, by End-user
  • 12.16. Key Findings
  • 12.17. Europe Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 12.17.1. Hospitals
    • 12.17.2. Diagnostic Laboratories
    • 12.17.3. Others
  • 12.18. Europe Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 12.19. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • 12.20. Europe Non-Invasive Prenatal Testing Market, by Country
  • 12.21. Key Findings
  • 12.22. Europe Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
    • 12.22.1. Germany
    • 12.22.2. France
    • 12.22.3. U.K.
    • 12.22.4. Spain
    • 12.22.5. Italy
    • 12.22.6. Rest of Europe
  • 12.23. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019-2027
  • 12.24. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

13. Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019-2027

  • 13.1. Key Findings
  • 13.2. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
  • 13.3. Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
    • 13.3.1. Materni21
    • 13.3.2. Harmony
    • 13.3.3. Panorama
    • 13.3.4. Verifi
    • 13.3.5. NIFTY
    • 13.3.6. Others
  • 13.4. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 13.5. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • 13.6. Asia Pacific Non-Invasive Prenatal Testing Market, by Application
  • 13.7. Key Findings
  • 13.8. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 13.8.1. Trisomy
    • 13.8.2. Microdeletions Symptoms
    • 13.8.3. Others (Including Sex Chromosomes Disorders)
  • 13.9. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 13.10. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • 13.11. Asia Pacific Non-Invasive Prenatal Testing Market, by Technology
  • 13.12. Key Findings
  • 13.13. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 13.13.1. NGS
    • 13.13.2. WGS
    • 13.13.3. Others
  • 13.14. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 13.15. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • 13.16. Asia Pacific Non-Invasive Prenatal Testing Market, by End-user
  • 13.17. Key Findings
  • 13.18. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 13.18.1. Hospitals
    • 13.18.2. Diagnostic Laboratories
    • 13.18.3. Others
  • 13.19. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 13.20. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • 13.21. Asia Pacific Non-Invasive Prenatal Testing Market, by Country
  • 13.22. Key Findings
  • 13.23. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
    • 13.23.1. China
    • 13.23.2. Japan
    • 13.23.3. India
    • 13.23.4. Malaysia
    • 13.23.5. Thailand
    • 13.23.6. Rest of Asia Pacific
  • 13.24. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019-2027
  • 13.25. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

14. Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019-2027

  • 14.1. Key Findings
  • 14.2. Latin America Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
    • 14.2.1. Materni21
    • 14.2.2. Harmony
    • 14.2.3. Panorama
    • 14.2.4. Verifi
    • 14.2.5. NIFTY
    • 14.2.6. Others
  • 14.3. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 14.4. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • 14.5. Latin America Non-Invasive Prenatal Testing Market, by Application
  • 14.6. Key Findings
  • 14.7. Latin America Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 14.7.1. Trisomy
    • 14.7.2. Microdeletions Symptoms
    • 14.7.3. Others (Including Sex Chromosomes Disorders)
  • 14.8. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 14.9. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • 14.10. Latin America Non-Invasive Prenatal Testing Market, by Technology
  • 14.11. Key Findings
  • 14.12. Latin America Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 14.12.1. NGS
    • 14.12.2. WGS
    • 14.12.3. Others
  • 14.13. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 14.14. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • 14.15. Latin America Non-Invasive Prenatal Testing Market, by End-user
  • 14.16. Key Findings
  • 14.17. Latin America Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 14.17.1. Hospitals
    • 14.17.2. Diagnostic Laboratories
    • 14.17.3. Others
  • 14.18. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 14.19. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • 14.20. Latin America Non-Invasive Prenatal Testing Market, by Country
  • 14.21. Key Findings
  • 14.22. Latin America Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
    • 14.22.1. Brazil
    • 14.22.2. Mexico
    • 14.22.3. Rest of Latin America
  • 14.23. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019-2027
  • 14.24. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

15. Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019-2027

  • 15.1. Key Findings
  • 15.2. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
    • 15.2.1. Materni21
    • 15.2.2. Harmony
    • 15.2.3. Panorama
    • 15.2.4. Verifi
    • 15.2.5. NIFTY
    • 15.2.6. Others
  • 15.3. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019-2027
  • 15.4. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • 15.5. Middle East & Africa Non-Invasive Prenatal Testing Market, by Application
  • 15.6. Key Findings
  • 15.7. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
    • 15.7.1. Trisomy
    • 15.7.2. Microdeletions Symptoms
    • 15.7.3. Others (Including Sex Chromosomes Disorders)
  • 15.8. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019-2027
  • 15.9. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • 15.10. Middle East & Africa Non-Invasive Prenatal Testing Market, by Technology
  • 15.11. Key Findings
  • 15.12. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
    • 15.12.1. NGS
    • 15.12.2. WGS
    • 15.12.3. Others
  • 15.13. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019-2027
  • 15.14. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • 15.15. Middle East & Africa Non-Invasive Prenatal Testing Market, by End-user
  • 15.16. Key Findings
  • 15.17. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
    • 15.17.1. Hospitals
    • 15.17.2. Diagnostic Laboratories
    • 15.17.3. Others
  • 15.18. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019-2027
  • 15.19. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • 15.20. Middle East & Africa Non-Invasive Prenatal Testing Market, by Country
  • 15.21. Key Findings
  • 15.22. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Country, 2018 and 2027
    • 15.22.1. South Africa
    • 15.22.2. GCC
    • 15.22.3. Rest of Middle East & Africa
  • 15.23. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019-2027
  • 15.24. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

16. Market Player - Competition Matrix

  • 16.1. Market Share Analysis, by Company
  • 16.2. Market Footprint Analysis
  • 16.3. Company Profiles
    • 16.3.1. Berry Genetics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Test Type Portfolio
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. BGI
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Test Type Portfolio
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. F. Hoffmann-La Roche Ltd
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Test Type Portfolio
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Laboratory Corporation of America Holdings
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Test Type Portfolio
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Kaiser Optical Systems, Inc
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Test Type Portfolio
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Agilent Technologies, Inc
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Test Type Portfolio
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Illumina, Inc
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Test Type Portfolio
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. NATERA, INC.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Test Type Portfolio
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. PerkinElmer Inc
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Test Type Portfolio
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Eurofins LifeCodexx AG
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Test Type Portfolio
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. IGENOMIX
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Test Type Portfolio
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 1 Cost Comparison Analysis
  • Table 2 Key Mergers & Acquisitions
  • Table 3 Technological Advancements
  • Table 4 Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, 2019?2027
  • Table 5 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 6 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 7 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 8 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 9 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Region
  • Table 10 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 11 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 12 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 13 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 14 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country
  • Table 15 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 16 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 17 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 18 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 19 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
  • Table 20 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 21 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 22 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 23 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 24 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
  • Table 25 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 26 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 27 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 28 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 29 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
  • Table 30 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
  • Table 31 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
  • Table 32 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
  • Table 33 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
  • Table 34 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region

List of Figures

  • Figure 1 Global Non-Invasive Prenatal Testing Market Value (US$ Mn) and Geographical Distribution
  • Figure 2 Global Non-Invasive Prenatal Testing Market Snapshot, By Segment
  • Figure 3 Market Opportunity Map
  • Figure 4 Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast
  • Figure 5 Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 6 Global Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 7 Y-o-Y Growth, Materni21
  • Figure 8 Y-o-Y Growth, Harmony
  • Figure 9 Y-o-Y Growth, Panorama
  • Figure 10 Y-o-Y Growth, Verifi
  • Figure 11 Y-o-Y Growth, NIFTY
  • Figure 12 Y-o-Y Growth, Others
  • Figure 13 Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 14 Global Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 15 Y-o-Y Growth, Trisomy
  • Figure 16 Y-o-Y Growth, Microdeletions Syndrome
  • Figure 17 Y-o-Y Growth, Others
  • Figure 18 Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 19 Global Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 20 Y-o-Y Growth, NGS
  • Figure 21 Y-o-Y Growth, WGS
  • Figure 22 Y-o-Y Growth, Others
  • Figure 23 Global Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 24 Global Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 25 Y-o-Y Growth, Hospitals
  • Figure 26 Y-o-Y Growth, Diagnostic Centers
  • Figure 27 Y-o-Y Growth, Others
  • Figure 28 Geographical Snapshot
  • Figure 29 Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Region
  • Figure 30 Global Non-Invasive Prenatal Testing Market Opportunity Analysis, by Region
  • Figure 31 Overview of NIPT Market In North America
  • Figure 32 North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 33 North America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 34 North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 35 North America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 36 North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 37 North America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 38 North America Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 39 North America Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 40 North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Country
  • Figure 41 North America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Country
  • Figure 42 Overview of NIPT Market In Europe
  • Figure 43 Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 44 Europe Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 45 Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 46 Europe Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 47 Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 48 Europe Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 49 Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 50 Europe Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 51 Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Country
  • Figure 52 Europe Non-Invasive Prenatal Testing Market Opportunity Analysis, by Country
  • Figure 53 Overview of NIPT Market In Asia Pacific
  • Figure 54 Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 55 Asia Pacific Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 56 Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 57 Asia Pacific Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 58 Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 59 Asia Pacific Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 60 Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 61 Asia Pacific Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 62 Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Country
  • Figure 63 Asia Pacific Non-Invasive Prenatal Testing Market Opportunity Analysis, by Country
  • Figure 64 Overview of NIPT Market In Latin America
  • Figure 65 Latin America Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 66 Latin America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 67 Latin America Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 68 Latin America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 69 Latin America Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 70 Latin America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 71 Latin America Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 72 Latin America Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 73 Latin America Non-Invasive Prenatal Testing Market Value Share Analysis, by Country/Sub-region
  • Figure 74 Latin America Non-Invasive Prenatal Testing Market Opportunity Analysis, by Country/Sub-region
  • Figure 75 Overview of NIPT Market In Middle East & Africa
  • Figure 76 Middle East and Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type
  • Figure 77 Middle East and Africa Non-Invasive Prenatal Testing Market Opportunity Analysis, by Test Type
  • Figure 78 Middle East and Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Application
  • Figure 79 Middle East and Africa Non-Invasive Prenatal Testing Market Opportunity Analysis, by Application
  • Figure 80 Middle East and Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology
  • Figure 81 Middle East and Africa Non-Invasive Prenatal Testing Market Opportunity Analysis, by Technology
  • Figure 82 Middle East and Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by End-user
  • Figure 83 Middle East and Africa Non-Invasive Prenatal Testing Market Opportunity Analysis, by End-user
  • Figure 84 Middle East and Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Country/Sub-region
  • Figure 85 Middle East and Africa Non-Invasive Prenatal Testing Market Opportunity Analysis, by Country/Sub-region
  • Figure 86 Competition Metrics
  • Figure 87 Company Share Analysis
Back to Top